David J Yvars Group Ocugen, Inc. Transaction History

David J Yvars Group

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$1.18 - $1.98 $24,072 - $40,392	20,400 Added 96.36%	41,570 $64,000
Q1 2024 Apr 11, 2024	BUY	$0.5 - $1.83 $10,585 - $38,741	21,170 New	21,170 $34,000
Q3 2021 Oct 18, 2021	SELL	$6.36 - $8.51 $69,960 - $93,610	-11,000 Closed	0 $0
Q2 2021 Jul 21, 2021	BUY	$5.52 - $15.68 $60,719 - $172,480	11,000 New	11,000 $88,000

123

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $169M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of David J Yvars Group, based on Form 13F filings with the SEC.

Stay updated on David J Yvars Group with notifications on news.